Inspire Veterinary (IVP) regains Nasdaq stockholders’ equity compliance

Rhea-AI Filing Summary

Inspire Veterinary Partners, Inc. reports that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), known as the stockholders’ equity requirement. Nasdaq notified the company on August 26, 2025 that, based on a filing made with the SEC on August 20, 2025, the company now meets the required level of stockholders’ equity for continued listing on the Nasdaq Capital Market. The company later issued a press release on September 2, 2025 to publicly announce that it is once again in compliance with this Nasdaq listing standard.

Positive

• Nasdaq equity compliance regained: Nasdaq notified the company on August 26, 2025 that Inspire Veterinary Partners is again in compliance with Listing Rule 5550(b)(1), reducing near-term delisting risk tied to stockholders’ equity.

Negative

• None.

Insights

Equity Markets & Listing Standards Analyst

Inspire Veterinary restored compliance with Nasdaq’s stockholders’ equity rule, reducing near-term delisting risk.

The company had previously been notified on April 10, 2025 that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum level of stockholders’ equity for continued listing on the Nasdaq Capital Market. On August 26, 2025, Nasdaq formally advised that Inspire Veterinary Partners had regained compliance, based on a filing the company made with the SEC on August 20, 2025.

This development is favorable because it means the company currently satisfies this key listing requirement and removes an immediate trigger for potential delisting tied to stockholders’ equity. The company also issued a press release on September 2, 2025, signaling an intent to keep investors informed about its listing status. Future company filings will show whether the stockholders’ equity level remains sufficient to support ongoing Nasdaq compliance.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001939365 0001939365 2025-08-26 2025-08-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 26, 2025

INSPIRE VETERINARY PARTNERS, INC.

(Exact name of registrant as specified in its charter)

Nevada		001-41792		85-4359258
(State or other jurisdiction		(Commission File Number)		(I.R.S. Employer
of incorporation)				Identification No.)

780 Lynnhaven Parkway, Suite 400 Virginia Beach, VA		23452
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (757) 734-5464

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.0001		IVP		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

As previously reported, on April 10, 2025, Inspire Veterinary Partners, Inc. (the “Company”) received notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not compliant with Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”).

On August 26, 2025, the Company received formal notification from Nasdaq that it had regained compliance with the Stockholders’ Equity Requirement, based on the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 20, 2025.

On September 2, 2025, the Company issued a press release announcing its compliance with Nasdaq’s Stockholders’ Equity Requirement. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release dated September 2, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 2, 2025	INSPIRE VETERINARY PARTNERS, INC.
	By:	/s/ Kimball Carr
	Name:	Kimball Carr
	Title:	President and Chief Executive Officer

2

FAQ

What did Inspire Veterinary Partners (IVP) announce in this 8-K?

Inspire Veterinary Partners reported that Nasdaq formally notified the company on August 26, 2025 that it had regained compliance with Nasdaq Listing Rule 5550(b)(1), the stockholders’ equity requirement for continued listing on the Nasdaq Capital Market.

Which Nasdaq rule is now satisfied by Inspire Veterinary Partners (IVP)?

The company is now in compliance with Nasdaq Listing Rule 5550(b)(1), referred to as the Stockholders’ Equity Requirement for companies listed on the Nasdaq Capital Market.

Why was Inspire Veterinary Partners (IVP) previously out of compliance with Nasdaq?

On April 10, 2025, Nasdaq’s Listing Qualifications Department notified Inspire Veterinary Partners that it was not compliant with Nasdaq Listing Rule 5550(b)(1), meaning its stockholders’ equity did not meet the required threshold at that time.

What triggered Nasdaq’s decision that IVP had regained compliance?

Nasdaq based its determination on a company filing made with the Securities and Exchange Commission on August 20, 2025, which showed that Inspire Veterinary Partners met the stockholders’ equity requirement again.

How did Inspire Veterinary Partners (IVP) communicate this Nasdaq compliance update to investors?

The company issued a press release dated September 2, 2025 announcing that it had regained compliance with Nasdaq’s Stockholders’ Equity Requirement, and filed that press release as Exhibit 99.1 to this 8-K.

Does this 8-K mention any changes to Inspire Veterinary Partners’ Nasdaq listing status?

Yes. It indicates that the company has returned to compliance with Nasdaq’s stockholders’ equity listing standard, supporting the continued listing of its common stock on the Nasdaq Capital Market under the symbol IVP.